Join
Live feed
·
INSIDERFilingvia Quantisnow
Kymera Therapeutics Inc. logo

Chief Medical Officer Gollob Jared was granted 17,650 shares and sold $916,669 worth of shares (10,508 units at $87.24), increasing direct ownership by 6% to 117,134 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KYMR (Kymera Therapeutics Inc.) and more on Quantisnow.